NPI: 1689626749 · FORT MILL, SC 29708 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/17/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/17/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,332 | $49K |
| 2019 | 3,577 | $62K |
| 2020 | 2,610 | $44K |
| 2021 | 2,009 | $35K |
| 2022 | 2,236 | $25K |
| 2023 | 145 | $7K |
| 2024 | 325 | $16K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 8,156 | 752 | $223K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 773 | 148 | $12K |
| A4657 | Syringe, with or without needle, each | 743 | 414 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 389 | 155 | $878.84 |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,517 | 186 | $238.59 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 45 | 24 | $120.53 |
| 83970 | 87 | 73 | $116.87 | |
| 82728 | 43 | 36 | $29.86 | |
| 85041 | 171 | 123 | $26.89 | |
| 85048 | 171 | 123 | $26.76 | |
| 85045 | 63 | 50 | $12.77 | |
| 83550 | 38 | 36 | $11.42 | |
| 83540 | 38 | 36 | $8.04 |